Toripalimab is a PD-1 inhibitor, a type of tumor immunotherapeutic drug, mainly used for the treatment of malignant tumors such as melanoma and nasopharyngeal carcinoma. Its common side effects include fatigue, rash, pruritus, diarrhea, etc.; severe side effects may involve immune-related adverse reactions (e.g., pneumonia, hepatitis, colitis) or endocrine abnormalities, which require prompt medical intervention. Patients must take the medication strictly as prescribed by their doctor and undergo regular physical indicator monitoring.
Common Side Effects
Skin reactions
Rash, pruritus, dry skin, etc. These can usually be relieved with moisturizers or topical medications.
Gastrointestinal symptoms
Diarrhea, nausea, decreased appetite. Mild symptoms can be managed with dietary adjustments, while severe cases require medical attention.
Systemic reactions
Fatigue, fever. Rest and close observation of symptom changes are recommended.
Severe Side Effects (Seek Immediate Medical Attention)
Immune-related inflammation
Such as pneumonia (cough, dyspnea), hepatitis (jaundice, abdominal pain), colitis (severe diarrhea), or thyroid dysfunction (changes in heart rate, weight fluctuations).
Other organ damage
Rare but may involve the heart, kidneys, or nervous system, presenting as chest pain, decreased urine output, limb numbness, etc.
Precautions for Medication
Regular examinations
Monitor blood routine, liver and kidney function, and thyroid function during treatment.
Timely symptom reporting
Contact a doctor immediately if persistent fever, dyspnea, severe diarrhea, or skin ulceration occurs.
Dosage adjustment
Some patients may need to suspend or discontinue treatment due to side effects, which must be evaluated and determined by a doctor.
Important Notes
Toripalimab is a prescription drug. Do not purchase or adjust the dosage without authorization; it must be used strictly under the guidance of an oncologist.
Inform your doctor of your medical history (e.g., autoimmune diseases, infections, etc.) before treatment to reduce the risk of complications.
Long-term monitoring for delayed immune reactions (e.g., hypophysitis, type 1 diabetes) is still required even after drug discontinuation.
If suspected side effects occur, please seek re-examination at a formal medical institution to avoid delaying treatment.
